Background
Background
Several approaches have been developed to score individual samples against molecular signatures (or gene sets), including: ssGSEA (single sample gene set enrichment analysis) [2] , GSVA (gene set variation analysis) [3] , PLAGE (pathway level analysis of gene expression) [4] and combining z-scores [5] . Hänzelmann et al. (2013) implemented all four of these methods within the R/Bioconductor package GSVA and performed a detailed comparison. It should be noted that GSVA, PLAGE and z-scores use data from all samples in the very first step to estimate gene distributions; GSVA performs kernel density estimation of the expression profile for each gene across all samples, while PLAGE and z-scores apply standardisation methods. Although ssGSEA normalises the scores across samples, this is the final step and it can be disabled. Some methods also make assumptions about the data which may be unsuitable in certain cases, for instance, PLAGE and combined z-scores are parametric methods that assume normality of expression profiles, while the combined z-scores method additionally makes an independence assumption for genes in a gene set [3] .
Here, we introduce a rank-based single sample scoring method, singscore. Using breast cancer data and several gene expression signatures we compare our approach to the above methods. The singscore method is simple, making the scores directly interpretable (as a normalised mean percentile rank), and our comparisons show that it is not only fast, but it also produces stable and reproducible scores regardless of the composition and number of samples within the data. Due to the independence of samples in computing scores, when within-sample effects such as RNA-seq gene length bias [6, 7] , GC content bias [8] , and other technical artefacts are properly corrected [9] [10] [11] , we believe this method may be more robust to unwanted variation that exists across samples. Furthermore, we include examples from real cancer data to show visualisation options and applications of the simple scoring method in molecular phenotyping and a clinical context.
Methods

The singscore method
For a sample transcriptome which has been corrected for technical within-sample bias (i.e. RPKM, TPM, or RSEM data for RNA-seq), genes are ranked by increasing mRNA abundance. Given an expression signature with expected up regulated genes the mean rank of this gene set in the ordered data is calculated; if the gene set also has a down regulated component, the ranks are reversed before the mean rank of the downset is calculated. Mean ranks are separately normalised (relative to theoretical minimum and maximum scores), and then summed (if an expected downregulated set is present), before centering on zero. A sample with a high score can be interpreted as having a transcriptome which is concordant to the specified signature, and scores reflect the relative mean percentile rank of the target gene sets within each sample.
Mathematically, the scores are defined as:
Where:
• is the gene set direction (i.e. expected up-or down-regulated genes);
• , is the score for sample against the directed gene set;
• , is the rank of gene in the directed gene set (decreasing abundance for expected upregulated genes and decreasing abundance for expected downregulated genes);
•
, is number of genes in the expected up-or down-regulated gene set that are observed within the data (i.e. missing genes are excluded);
• ̅ , is the normalised score for sample against those genes, and;
, is the number of total genes in sample .
As noted above, the up-and down-scores for each sample are normalized against the theoretical minimum and maximum values calculated under the assumption of non-overlapping ranks (determined from the sum of arithmetic series), summed, and then centered on zero. A static centering is performed in a scoreindependent manner such that sample independence is maintained. If required, the significance of a score can be evaluated using a permutation test, where scores are computed per sample for random gene sets of the same size as the set of interest to form a null distribution ( Fig. S1 in Additional File 1). The approach is similar to a Wilcoxon rank sum test if the gene-set consists of either one of up-regulated or down-regulated genes.
Implementation of singscore
All statistical analyses were performed using R (v3.3 and greater) and Bioconductor (v3.4 and greater). We have produced a singscore package implementing this method, and included several visualisation functions that produce both static and interactive (.html) plots using ggplot2 [12] and plotly [13] respectively.
Other scoring methods
The R/Bioconductor package GSVA was used to evaluate the performance of the GSVA, ssGSEA, z-score and PLAGE methods [14] . We have slightly modified this approach to account for bidirectional signatures where both expected up-and down-regulated gene sets were available, with a method previously described by
Foroutan et al. [1] . Additionally, we include ssGSEA !Norm by removing the (final) normalisation step of the ssGSEA method, allowing us to test the performance in data sets with smaller sample sizes.
Data
In this study, we used The Cancer Genome Atlas (TCGA) breast cancer [15] RNA-seq data (RSEM normalised) and microarray data (RMA normalised from Agilent4502A_07_03 microarray platform), the Cancer Cell Line Encyclopaedia (CCLE) [16] 
Data processing
The SRA files from Daemen et al. were obtained on July 2016 (GSE), and converted to fastq files using the fastq-dump function in the SRA toolkit [21] . Reads were aligned to human genome hg19 using the Rsubread package [22] in R/Bioconductor, and count level data were obtained using the featureCount function with default parameters. The edgeR package [23] was used to calculate RPKM values. For all other data sets, we used processed data available online (see Table 1 ).
Comparing the stability of single scores obtained by scoring methods
Method stability was examined using 500 of the overlapping samples between the TCGA breast cancer RNA-seq and microarray data (Sample IDs in Suppl. Table 1 ). Sub-sampling was then performed to vary the number of samples and genes present for each evaluation. To examine sample size effects upon a given sample, , two data sets were created by sampling from both the RNA-seq and microarray data to select the sample and − 1 other random samples. The score for sample was then computed using all listed methods, and this process was repeated across all 500 samples at a given sample size, such that there are 500 matched scores in total from each of the microarray data and RNA-seq data. The Spearman's rank correlation coefficient and the concordance index were then calculated between sample scores from the microarray and the RNA-seq data. We note that for some methods, sampling data in such a manner can modify the background samples for a sample of interest, reflecting the effect of overall sample composition on the final scores. A similar analysis was performed by varying the number of genes in the sub-sampled data, however, note that when sampling genes from the original data, all genes present in the signature of interest were retained.
We performed this analysis with undirected epithelial and mesenchymal gene sets [24] , and a directed TGFβ-EMT signature [1] , using test combinations of sample numbers = (2, 5, 25, 50, 500) and gene numbers = (500, 1000, 5000, 10000, ). The complete set of permutations was repeated 20
times to ensure accuracy of estimates and to estimate the error margins of measurements.
Comparing the computation time for scoring methods
To compare the computational time of each scoring method, we randomly selected 1000 gene sets from MSigDB [25, 26] and scored the TCGA breast cancer RNA-seq data using all methods listed above. The analysis was repeated 10 times to improve coverage of signatures on MSigDB and allow error estimates. This comparison was performed on UNIX machine (Intel(R) Xeon ® CPU E5-2690 v3 @ 2.60GHz) using only one core without code parallelisation.
Results
Technical considerations for simple scoring method
Simple scores are highly stable compared to other scoring approaches
The performance of singscore was compared to GSVA, z-score, PLAGE, ssGSEA, and a modified ssGSEA without normalization (ssGSEA !Norm ), using both the TCGA breast cancer microarray and RNA-seq data.
Overlapping samples between the two platforms (n Samples = 500) were scored using three gene signatures, epithelial (Epi), mesenchymal (Mes) and TGFβ-induced EMT (TGFβ-EMT) signatures [24] while the number of samples and genes in the data were modified (as described in the Methods section). The Spearman's correlations and concordance index [27] between sample scores from the two platforms were calculated.
Our results show a high stability for singscore and ssGSEA modified to run without normalisaton (ssGSEA !Norm ) compared to the other methods when varying the sample number and number of genes in the data set (Figure 1 , Suppl. Figures 2 and 3 ) reflecting sample composition effects. While all methods performed well for large data sets, PLAGE had the worst performance with sub-sampled data, while GSVA, z-score and ssGSEA show a reduced stability compared to singscore and ssGSEA !Norm in data sets with small sample sizes (n Samples < 25). This demonstrates that singscore may be particularly useful in cases where data sets are relatively small, or where there may be a heterogeneous sample composition (i.e. samples across different cancer subtypes with unbalanced frequencies). Although PLAGE appeared to perform poorly for signatures with both expected up-and down-regulated gene sets, as discussed below, the underlying metric was not designed to account for such directionality.
An important factor for computational tools is run time, and we note that ssGSEA !Norm and ssGSEA have much longer compute times than all other methods when tested with random signatures from MSigDB [25, 26] (Method section, Suppl. Figure 1) , whereas our approach is very fast and comparable with PLAGE and zscore.
Scores obtained by singscore are not influenced by (unwanted) variation across samples
An important consideration with transcriptomic data is the presence of (unwanted) variation across or within some samples (i.e. batch effects); for methods that use all the samples within a dataset, the score of an individual sample can thus be affected by artefacts within other samples. Further, for cancer data sets, the scores of each sample will be affected by the relative composition of the overall study (i.e. they could be affected by including/excluding different subtypes). Our comparison between scores derived from the microarray (n Genes = 17814) and RNA-seq (n Genes = 14202) expression data for varying numbers of samples (n Samples = 2-500, Figure 1) shows changes in the scores of an individual sample with different sample backgrounds, when calculated by PLAGE, GSVA, z-score, and ssGSEA methods, particularly with smaller data sets; while the singscore and ssGSEA !Norm metrics are more robust to changes in sample composition and size, due to the independence of scores between samples. We also compared independent transcriptomic data for cell lines collected from two independent studies [16, 17] , and calculated both the epithelial and mesenchymal scores for the cell lines. There were 32 cell lines present in each dataset, which enabled us to explore the consistency of EMT scoring in independent datasets. The scores are largely consistent (Figure 2A ), despite differences in computational pipelines, gene expression metrics and experimental protocol of the two datasets. For the few cell lines that show substantial variation in scores we cannot exclude the possibility that biological variation between the independently cultured cells might underpin the observed differences. We note that all the cell lines with larger variations in mesenchymal scores are from luminal sub-groups with consistently high epithelial scores across the two datasets, while cell lines with the highest variability in epithelial scores are from the claudinlow sub-groups which also show consistently high mesenchymal scores (Figure 2A ). The variation in epithelial and mesenchymal scores for three representative cell lines (HCC1428, HCC202, and MDAMB231) is shown in Figure 2B .
Application of simple scoring method
Obtaining landscapes of molecular phenotypes
Scoring samples against multiple molecular signatures and plotting them in 2D or 3D can be useful to stratify 
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against their respective mesenchymal and epithelial signatures from TZ Tan, QH Miow, Y Miki, T Noda, S Mori, RY Huang and JP Thiery [24] , provides more refined stratification of patients and cell lines. For instance, only a subset of the aggressive claudin-low breast cancer subtype consistently shows high mesenchymal and low epithelial scores across the independent data sets ( Figure 3 ) [28] . These samples have different expression patterns compared to samples with high epithelial and low mesenchymal scores, representing a subset of less aggressive subtypes (Luminal). Each of these sub-groups can be further analysed, for example by comparing different omics data between these sub-groups, or by examining their associations with preclinical outcomes such as drug response.
Assessment of scores: beyond a single value
When ranking gene expression values of a sample in increasing order, a higher mean rank of the expected up-regulated gene set represents a higher concordance of the sample to the gene set, while lower ranks of expected down-regulated genes are associated with a higher concordance of the sample to the gene set.
Considering where gene ranks would sit within a sample with the maximum theoretical scores (see Methods), the expected up-and down-regulated gene sets should form an approximately bimodal distribution, with higher ranks for the up-and lower ranks for the down-set ( Figure 4A, sample 3) . For samples that are not strongly concordant with a signature, the distributions of genes are less coordinated, and often relatively uniform ( Figure 4A, sample 2) . To easily visualise the rank distribution of genes in the up-and down-gene sets, the singscore package provides static and interactive plots that display density and barcode plots for gene ranks in individual samples ( Figure 4A ). These plots help to interpret the score in the context of the ranked genes, and often demonstrate that up-and down-gene sets can vary in their dispersion, contributing to the range of ranks we observe. We often see that a low scoring sample may have an inverted pattern of expression ( Figure 4A , sample 1), or have no concordance with the gene set at all (i.e. randomly distributed genes across the ranks; Figure 4A , sample 2).
To illustrate these differences, we calculate median absolute deviation (MAD) of the gene set ranks to estimate relative rank dispersion. Plotting scores against dispersion for the samples in the TGFβ-EMT data shows that samples with a high total score also have lower dispersion, demonstrating more coordinated changes in the up-and/or down-sets in these samples ( Figure 4B) . It is also possible to look at the rank dispersion of the up-and down-sets to assess the performance of each of these sets separately. Figure 4B shows that genes in the up-set of TGFβ-EMT signature are more coordinated in samples compared to the down-set.
Discussion
We have described a rank-based single sample gene set scoring method, implemented in the singscore package. Our method can easily be applied on any high throughput transcriptional data from microarray or RNA
Accordingly, RNA abundance data formatted as RPKM, TPM, or RSEM can be used, with or without logtransformation, and/or filtering for genes with very low expression.
Using microarray and RNA-seq platforms of the TCGA breast cancer data, we show that our singscore approach yields stable scores for individual samples because they are treated independently from other samples, in contrast to GSVA, PLAGE, z-score, and ssGSEA. Although modifying ssGSEA to exclude the final normalization step also shows high stability, the lack of a single sample normalization/scaling step in ssGSEA !Norm hinders interpretability of scores, that is, it is difficult to make a distinction between a moderate score and a high score. Additionally, even with modification, ssGSEA cannot actually be applied to a single sample. In contrast, singscore includes per sample normalisation and scaling by considering the theoretical minimum and maximums for scores in each sample, and can be applied to a single sample in isolation.
We show that current implementations of both ssGSEA !Norm and ssGSEA through the GSVA package are computationally much slower than all the other methods for scoring samples against a large number of random signatures (Suppl. Figure 1 ), while our approach is fast. The poor performance of PLAGE (Suppl. It is also important to note that there are a few more recent single sample analysis approaches, including multiple omics gene set analysis (moGSA) [29] and personalized pathway alteration analysis (PerPAS) [30] , which have not been discussed here, as they are fundamentally different from our approach. For example, moGSA needs multiple types of large-scale ('omics') data for each individual sample and it integrates information across these data using multivariate factor analysis [29] , and thus it may not be applicable for samples with only transcriptomic data. Alternately, PerPAS needs topological information for each gene to perform pathway analysis, and further uses either a control sample or a cohort of samples based on which the gene expression data in single sample are normalised [30] ; these requirements make this method unsuitable for many available datasets.
Methods that need a large number of samples to calculate a precise and stable score for each individual sample often need to be re-run across a large data set whenever a few new samples are required to be scored. It adds an extra layer of complexity to the already complicated scoring methods. Our single sample scoring method provides a simple and easy-to-understand pipeline which performs as well as the other comparable scoring methods in large data sets, and outperforms other methods in smaller data sets. Several visualization options at both bulk and single sample level are provided to enable users to explore genes, gene signatures, and samples in more depth.
Conclusion
In the context of personalised medicine, we often have data from an individual patient, or from a small number of samples in pre-clinical experiments. Current scoring methods are parametric and/or depend on large number of samples to produce stable scores, while singscore generates scores that are stable across a range of sample sizes and numbers of measured genes. This is due to it being a non-parametric, rank-based, and truly single sample method. Moreover, scores generated by our method are less likely to be influenced by batch effects across samples and can be normalised at a single sample level, resulting in easilyinterpretable scores. 
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